Specifically, CCL2 production was impacted by the loss of CD44 in both the Hs578T and MDA-MB-231 cells, which is relevant to breast cancer, as CCL2 has been shown to recruit monocytes into the primary tumor and promote metastasis [35,36,37,38]. Here, CD44 is linked to breast carcinoma.